Oral Administration Device with Dissolving Substrate

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current oral medication administration methods, both solid and liquid forms, face challenges such as solubility issues, stability problems, and taste concerns, particularly for children and the elderly, with liquid forms being unsatisfactory due to volume control difficulties and recrystallization issues, and solid forms like effervescent tablets being unsuitable for all patients.

Innovation Solution

A device featuring an elongated tubular body with a non-return valve and substrates composed of a neutral insoluble support coated with a soluble layer containing an active ingredient that changes color upon dissolution, ensuring precise and reproducible medication delivery.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If liquid pharmaceutical forms are used, then ease of administration is improved, but stability and solubility control deteriorate

Engineering Contradiction:
Improveease of administrationVSAvoidstability
Core Design Contradiction:
Ease of operationVSStability of the object's composition

Solution Approach 1:

The device segments the medication delivery process by separating the solid substrate containing active ingredients from the liquid medium. The substrate is designed to dissolve progressively in the liquid, allowing controlled release of medication while maintaining stability during storage. This segmentation resolves the contradiction by enabling easy liquid administration while preserving stability through the solid substrate structure.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the physical state parameter of the medication from solid (tablets) or unstable liquid to a controlled dissolution system where solid substrate transforms into liquid solution during administration. The substrate is designed with specific solubility characteristics that allow it to dissolve at controlled rates, transforming the medication from stable solid form to easily administrable liquid form only when needed.

Inventive Principle:
Principle #35Parameter changes

2Measurement precision

If small volumes of solute are used, then dosage precision is improved, but dissolution control and taste deteriorate

Engineering Contradiction:
Improvedosage precisionVSAvoiddissolution control
Core Design Contradiction:
Measurement precisionVSStability of the object's composition

Solution Approach 1:

The device employs dynamic dissolution where the substrate progressively dissolves in the liquid medium during the administration process. The dissolution rate is controlled by the substrate's physical and chemical properties, allowing precise dosage delivery. The dynamic nature of the dissolution process ensures complete release of active ingredients while maintaining acceptable taste through controlled interaction with the liquid.

Inventive Principle:
Principle #15Dynamics

3Stability of the object's composition

If effervescent tablets are used, then stability is improved, but dissolution time and sodium content deteriorate

Engineering Contradiction:
ImprovestabilityVSAvoiddissolution time
Core Design Contradiction:
Stability of the object's compositionVSLoss of time

Solution Approach 1:

The invention extracts the effervescent mechanism (carbonate/bicarbonate systems) from the medication formulation and replaces it with a simpler soluble substrate system. This extraction eliminates the need for high sodium content while maintaining stability. The substrate dissolves directly in the liquid medium without requiring effervescent reactions, significantly reducing dissolution time while preserving the stability benefits of solid pharmaceutical forms.

Inventive Principle:
Principle #2Taking out (Extraction)

4Ease of operation

If soluble substrates are used in straws, then ease of administration is improved, but product loss and dosing accuracy deteriorate

Engineering Contradiction:
Improveease of administrationVSAvoidproduct loss
Core Design Contradiction:
Ease of operationVSLoss of substance

Solution Approach 1:

The device uses a substrate that is designed to dissolve partially or completely during the administration process, with the dissolution extent controlled by the substrate's solubility characteristics. The substrate provides a reservoir of active ingredients that dissolves as the patient consumes the liquid, ensuring complete dosage delivery without loss. The insoluble or partially soluble nature of the substrate prevents product loss while maintaining ease of administration.

Inventive Principle:
Principle #16Partial or excessive action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The device allows for exact and reproducible medication administration, preventing leakage and ensuring the patient ingests the correct dose, with the color change indicating complete medication absorption, addressing the limitations of existing forms.

Implementation Method 1

an external coating layer (22) colored and soluble containing at least one active principle and having a coloring different from that of the neutral support (20)

Methodology Applied
Scientific EffectDissolution: Solvation

Implementation Method 2

capable of changing color when all of the active principle has been effectively dissolved and absorbed

Methodology Applied
Scientific EffectColor change: Thermochromism

Implementation Method 3

a non-return valve (16) at one of the two ends

Methodology Applied
Scientific EffectOne-way flow control: Valve

Data Source

PatentEP2185134B1Device for the oral administration of active principles
Publication Date: 2017.11.22 UNITHER PHARMA INC
  • EP2185134B1 patent drawingFigure 1~2
  • EP2185134B1 patent drawingFigure 3~4
  • EP2185134B1 patent drawingFigure 5~6

AI summary

The subject of the invention is a device (10) for the oral administration of medicaments, taking the form of an elongate tubular body comprising means (12, 14) capable of taking in or expelling a liquid at each end, a non-return valve (16) at one of the two ends, and at least one substrate (18) formed by at least one inert supporting member (20) and a soluble coating layer (22) having a different colour from that of the inert supporting member and containing at least one active principle.